Bullous pemphigoid induced by topical PUVASOL.
2014
Najeeba Riyaz, and
Naazneen Nasir, and
Valiaveetil Bindu, and
Sarita Sasidharanpillai
Department of Dermatology and Venereology, Government Medical College, Kozhikode, Kerala, India.
UI
MeSH Term
Description
Entries
D008875
Middle Aged
An adult aged 45 - 64 years.
Middle Age
D010391
Pemphigoid, Bullous
A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
Pemphigoid,Bullous Pemphigoid,Pemphigoids
D011701
PUVA Therapy
Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA).
Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D005260
Female
Females
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287
Administration, Topical
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D013472
Sunlight
Irradiation directly from the sun.
Sunshine
Related Publications
Najeeba Riyaz, and
Naazneen Nasir, and
Valiaveetil Bindu, and
Sarita Sasidharanpillai